Health and Wellness Market in China
对这份报告感兴趣?
立即获取免费样品!
Health and wellness refers to the state of being in good physical, mental, and emotional health. It encompasses a wide range of factors, including diet, exercise, sleep, stress management, and social support. Maintaining good health and wellness is important for overall well-being and quality of life. It can help to prevent chronic diseases, such as heart disease, diabetes, and cancer, and can improve mental health and cognitive function. 根据最新研究, the health and wellness market in China is poised to grow by USD 1.0 trillion during 2023-2029, 复合年增长率为 8.96% 在预测期内.
这份行业报告提供了中国市场的市场预测, 其次是类型的详细分析. The China market data on health and wellness can be segmented by type: consumer healthcare, healthcare infrastructure, healthcare services, non-pharmaceutical products.
The China health and wellness market is highly competitive. The prominent players operating in the China health and wellness market include Ikang Healthcare Group Inc., Jiangsu Hengrui Medicine Co. 有限公司, Meinian Onehealth Healthcare Holdings Co. 有限公司, Ping An Health Insurance Company of China Ltd., Shanghai Pharmaceuticals Holding Co. 有限公司, Sino Biopharmaceutical Limited, Yunnan Baiyao Group Co. 有限公司.
以数据为中心的报告重点关注市场趋势, 各细分市场的现状和前景. 全面覆盖不同细分市场, 该报告对于现有参与者来说是宝贵的资产, 新进入者和未来投资者.
为什么购买这份报告?
▹ Get a detailed picture of the China Health and Wellness Market
▹ Identify segments/areas to invest in over the forecast period in the China Health and Wellness Market
▹ 了解竞争环境, 市场的领先参与者
▹ Excel 格式的市场预估,方便跨场景分析.
▹ 三个月的策略咨询和研究支持.
▹ 为单用户许可证提供打印验证.
部分 1. 概括
部分 2. 介绍
学习时段
地理范围
市场细分
部分 3. Health and wellness market overview
部分 4. 按类型划分的市场细分
Consumer healthcare
Healthcare infrastructure
Healthcare services
Non-pharmaceutical products
部分 5. 重点企业
Ikang Healthcare Group, 公司.
Jiangsu Hengrui Medicine Co., 有限公司.
Meinian Onehealth Healthcare Holdings Co., 有限公司.
Ping An Health Insurance Company of China, 有限公司.
Shanghai Pharmaceuticals Holding Co., 有限公司.
Sino Biopharmaceutical Limited
Yunnan Baiyao Group Co., 有限公司.
部分 6. 方法
Ikang Healthcare Group, 公司.
Jiangsu Hengrui Medicine Co., 有限公司.
Meinian Onehealth Healthcare Holdings Co., 有限公司.
Ping An Health Insurance Company of China, 有限公司.
Shanghai Pharmaceuticals Holding Co., 有限公司.
Sino Biopharmaceutical Limited
Yunnan Baiyao Group Co., 有限公司.
报告属性 | 细节 |
---|---|
基准年 | 2022 |
预测年份 | 2023-2029 |
复合年增长率 (2023-2029) | 8.96% |
页数 | 18 |
行业参与者 | Ikang Healthcare Group Inc., Jiangsu Hengrui Medicine Co. 有限公司, Meinian Onehealth Healthcare Holdings Co. 有限公司, Ping An Health Insurance Company of China Ltd., Shanghai Pharmaceuticals Holding Co. 有限公司, Sino Biopharmaceutical Limited, Yunnan Baiyao Group Co. 有限公司. |
中国多重耐药革兰氏阳性菌抗生素市场(按类型) (达托霉素, 利奈唑胺, 替考拉宁, 替加环素), 按给药途径 (可注射的, 口服), 行业快照, 2023-2029
中国溃疡性结肠炎 (UC) 按类型划分的市场 (轻度溃疡性结肠炎, 中度至重度溃疡性结肠炎), 副产品 (英夫利昔单抗, 美沙拉嗪, 柳氮磺吡啶 (SS), 其他的), 行业快照, 2023-2029
请填写我们的表格,我们会尽快回复您.